EMD-35535

Single-particle
4.3 Å
EMD-35535
3D View Gallery
Deposition: 03/03/2023
Map released: 16/08/2023
Last modified: 16/08/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-35535

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Human ornithine transcarbamylase expressed using mRNA lipid nanoparticles in human cells and PEGylated

EMD-35535

Single-particle
4.3 Å
EMD-35535
3D View Gallery
Deposition: 03/03/2023
Map released: 16/08/2023
Last modified: 16/08/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Human ornithine transcarbamylase

Deposition Authors: Kondo K , Yamazaki K , Kubara K , Ishii S , Suzuki Y, Miyazaki T, Mitsuhashi K, Ito M, Tsukahara K
Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice.
Yamazaki K , Kubara K , Ishii S , Kondo K , Suzuki Y, Miyazaki T, Mitsuhashi K, Ito M, Tsukahara K
(2023) Mol Ther Nucleic Acids , 33 , 210 - 226
PUBMED: 37520683
DOI: doi:10.1016/j.omtn.2023.06.023
ISSN: 2162-2531
Grant Support: